OmegaBrite(R) High EPA Omega-3 Supplement Earns Nutrition Business Journal Business...
* Reuters is not responsible for the content in this press release.
OmegaBrite(R) High EPA Omega-3 Supplement Earns Nutrition Business Journal Business Achievement Award In recognition of the creation of high concentrate Omega-3 supplements category WALTHAM, Mass., April 15 /PRNewswire/ -- OmegaBrite, the first high EPA, high concentrate Omega-3 on the market, known for elevating the standards of the entire Omega-3 industry for purity concentration and scientific efficacy, today announced that it has been recognized as the Product of Merit in the 2007 Nutrition Business Journal Business Achievement Awards for creating the category of high EPA supplements. These awards acknowledge outstanding leaders in the nutrition marketplace in categories ranging from the latest developments in research and technology to the newest supplements brought to market. According to the Nutrition Business Journal Business Achievement Awards judging panel, "OmegaBrite was the first high concentrate, high EPA Omega-3 available to the public and created awareness of the importance of Omega-3 and the importance of EPA as the body's natural anti-inflammatory molecule. OmegaBrite not only created the category of high EPA concentrate Omega-3 but also elevated the standards of the entire industry for purity, concentration and scientific efficacy." OmegaBrite will receive the award at the annual Nutrition Business Journal Awards Summit in July 2008 in Dana Points, CA. "We are pleased that OmegaBrite has been recognized by Nutrition Business Journal as the Product of Merit," said Dr. Carol A. Locke, President of OmegaBrite. "At OmegaBrite, we are proud to be at the forefront of this industry in bringing attention to the positive benefits of high EPA Omega-3 fish oils. It is profoundly gratifying to know that with OmegaBrite we are providing a safe, natural way for consumers to obtain the benefits of essential Omega-3s." OmegaBrite was created in 1999 by Carol A. Locke, M.D., who foresaw that high EPA, Omega-3 fatty acids in highly concentrated form would prove a safe and effective treatment of mood disorders, cardiac health, ADD/ADHD, cognitive development and joint pain, as well as a preventative measure for all people. To learn more about OmegaBrite, please visit http://www.omegabrite.com. Journalists seeking information should contact Rachel Greenstein, Warner Communications at 617-569-6269 or firstname.lastname@example.org. About OmegaBrite(R) Scientifically formulated by Carol Locke, M.D., while on faculty at Harvard Medical School, OmegaBrite is a pharmaceutical-quality, concentrated high EPA Omega-3 fatty acid supplement from fish oil promoting positive mood, cardiac and joint health, and overall well being. Located in Waltham, Massachusetts, the company uses the most advanced manufacturing processes to provide the highest purity Omega-3 products on the market. More information can be found at http://www.omegabrite.com. SOURCE OmegaBrite Rachel Greenstein, +1-617-569-6269, email@example.com, or Erin Vadala, +1-978-468-3076, firstname.lastname@example.org, both of Warner Communications, for OmegaBrite
- South Korea expands air defense zone to partially overlap China's |
- U.S. war veteran released by North Korea returns home |
- Dynasty's Congress party punished in Indian state elections
- Thai PM proposes referendum on her future as protesters prepare big push
- Pennsylvania newlyweds "just wanted to murder someone together:" police